Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.03 USD | -1.30% | -4.72% | -7.20% |
Apr. 24 | Gain Therapeutics, Inc. Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287 | CI |
Apr. 08 | Gain Therapeutics Names Gene Mack as CFO | MT |
Chart: Technical Analysis
- Stock Market
- Equities
- GANX Stock
- Charts Gain Therapeutics, Inc.